2012
DOI: 10.1016/j.placenta.2012.01.015
|View full text |Cite
|
Sign up to set email alerts
|

Thymic stromal lymphopoietin promotes the proliferation of human trophoblasts via phosphorylated STAT3-mediated c-Myc upregulation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
11
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(12 citation statements)
references
References 15 publications
1
11
0
Order By: Relevance
“…Bovine MYC was uniformly expressed in all the iBT cells lines, whereas the exogenous hMYC , which was integrated into all of the iBT cell lines, was not. The expression of endogenous bovine MYC in the cell lines is consistent with the demonstrated maintenance of Myc expression in mouse trophectoderm stem cells (Erlebacher, Price, & Glimcher, ); MYC overexpression inducing trophectoderm differentiation from human ESCs (Sumi, Tsuneyoshi, Nakatsuji, & Suemori, ); high expression of MYC in proliferative human cytotrophoblast tissue (Rydnert, Pfeifer‐Ohlsson, Goustin, & Ohlsson, ); MYC up‐regulation in the cytokine‐induced proliferation of human cytotrophoblast cells (Pu et al, ); MYC up‐regulation in the trophectoderm of bovine blastocysts treated with epidermal growth factor (Tetens, Kliem, Tscheudschilsuren, Navarrete Santos, & Fischer, ); and ectopic MYC expression increasing the efficiency of mouse induced trophectoderm stem cell derivation from embryonic fibroblasts (Benchetrit et al, ).…”
Section: Discussionsupporting
confidence: 72%
“…Bovine MYC was uniformly expressed in all the iBT cells lines, whereas the exogenous hMYC , which was integrated into all of the iBT cell lines, was not. The expression of endogenous bovine MYC in the cell lines is consistent with the demonstrated maintenance of Myc expression in mouse trophectoderm stem cells (Erlebacher, Price, & Glimcher, ); MYC overexpression inducing trophectoderm differentiation from human ESCs (Sumi, Tsuneyoshi, Nakatsuji, & Suemori, ); high expression of MYC in proliferative human cytotrophoblast tissue (Rydnert, Pfeifer‐Ohlsson, Goustin, & Ohlsson, ); MYC up‐regulation in the cytokine‐induced proliferation of human cytotrophoblast cells (Pu et al, ); MYC up‐regulation in the trophectoderm of bovine blastocysts treated with epidermal growth factor (Tetens, Kliem, Tscheudschilsuren, Navarrete Santos, & Fischer, ); and ectopic MYC expression increasing the efficiency of mouse induced trophectoderm stem cell derivation from embryonic fibroblasts (Benchetrit et al, ).…”
Section: Discussionsupporting
confidence: 72%
“…Studies in mice show that the embryonic-lethal phenotype seen in c-MYC-null animals can be largely corrected if the expression of this gene is maintained selectively in trophoblast (26,27). In humans, the rapid decline in MYC expression as primary term cytotrophoblast cells exit the cell cycle (28), together with the observation that JEG-3 choriocarcinoma cells have significantly reduced levels of proliferation in its absence, initially suggested a role in trophoblast regulation (29). Direct evidence is presented here; overexpression of miR-377 and let-7a reduced expression of both ERK and MYC and attenuated proliferation.…”
Section: Discussionmentioning
confidence: 99%
“…One final link that has been made between TSLP and immune tolerance is in maternal-fetal tolerance during pregnancy(Li & Guo, 2009). TSLP was produced and secreted by first semester trophoblasts, and tissue from normal pregnancies demonstrated a TH2 bias and higher levels of TSLP expression than samples from miscarriages (Guo et al, 2010; Pu et al, 2012; Wu, Guo, Jin, Liang, & Li, 2010). Thus, while TSLP expression and a TH2 bias may lead to disease progression in cancer, TSLP may contribute to tolerance at the maternal-fetal interface.…”
Section: Tslp-associated Diseasesmentioning
confidence: 95%